...
机译:Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial
University of California System,Univ Calif Los Angeles;
Clin Pesquisas & Ctr Estudos Oncol Ginecol & Ltda;
Dept Oncol,Natl Cheng Kung Univ HospSeoul Natl Univ Hosp,Seoul Natl UnivInst Canc Montpellier,Montpellier UnivPeninsula & South Eastern Haematol & Oncol GrpQueen Mary Hosp,Univ Hong KongCanc Hosp Chinese Acad Med Sci & Peking Union MedSarah Cannon Res Inst Tennessee OncolNottingham Univ Hosp,Univ NottinghamDept Breast Oncol,Aichi Canc Ctr HospDept Med Oncol,Antwerp Univ HospTom Baker Canc ClinEuropean Inst Oncol,IRCCSQuironsalud Grp,Int Breast Canc CtrColl Med,Univ UlsanInst Canc Estado Sao Paulo Octavio Frias OliveriaDept Surg,Natl Taiwan Univ HospHosp 1,Jilin UnivSite Rene Gauducheau,Inst Cancerol OuestComplejo Hosp Univ CorunaChinese Univ Hong KongIRCCS Osped San RaffaelePeter MacCallum CancAdv Canc Translat Res Inst,Showa Univ HospFac Biomed & Hlth Sci,Univ Europea Madrid;